Xellar Biosystems
Signal active
Organization
Contact Information
Overview
N/A
About
Industries
Biotechnology, Artificial Intelligence (AI), Pharmaceutical
Founded
2022
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Xellar Biosystems headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Pharmaceutical sector. The company focuses on Biotechnology and has secured $165.1M in funding across 12 round(s). With a team of 11-50 employees, Xellar Biosystems is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Xellar Biosystems, raised $13.8M. Discover more about their projects, partnerships, and impact on our platform.
Employees
N/A
Funding Rounds
Funding rounds
1
Investors
5
Lead Investors
0
Total Funding Amount
$13.8M
Details
1
Xellar Biosystems has raised a total of $13.8M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2024 | Seed | 13.8M |
Investors
Xellar Biosystems is funded by 8 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Yael Capital Management Limited | - | FUNDING ROUND - Yael Capital Management Limited | 13.8M |
| Xellar Biosystems | - | FUNDING ROUND - Xellar Biosystems | 13.8M |
| Xellar Biosystems | - | FUNDING ROUND - Xellar Biosystems | 13.8M |
| TriApex | - | FUNDING ROUND - TriApex | 13.8M |
Recent Activity
There is no recent news or activity for this profile.